HONG KONG, Nov. 12, 2025 /PRNewswire/ — How is artificial intelligence revolutionising diagnostic experiences? How can robotics enhance surgical precision? How far are we from achieving universal access to medical AI? What are the latest trends and future directions in medical technology development? These hotly debated topics, which have captured widespread social attention, were comprehensively addressed by dozens of leading industry experts at the 3rd CREATE Symposium, hosted by the Centre for AI and Robotics (CAIR), Hong Kong Institute of Science & Innovation (HKISI), and Chinese Academy of Sciences (CAS).

On October 27, the second day of the symposium continued the momentum set on day one, with stimulating academic exchanges and inspiring cross-sector dialogues. Discussions centred around the integration of engineering with healthcare, as well as the global expansion of medical technology. The forum served as a dynamic platform for exploring the pathways to industrialising medical technology and promoting intelligent healthcare worldwide, igniting engaging conversations among participants.

In his welcome remarks, Prof Gaofeng MENG, Deputy Director of CAIR, highlighted the importance of the CREATE Symposium as a vital platform for global medical technology collaboration. He noted that Hong Kong’s unique position, coupled with its innovation-driven approach, has become a catalyst for fostering deeper ties between China and the international community. “CREATE” is not merely the theme of this forum, but also a collective vision — one that seeks to push the boundaries of medical technology and contribute to the global advancement of healthcare.

In his opening remarks, Prof Hui HAN, Vice President of Qilu Hospital of Shandong University, shared insights into the hospital’s pioneering efforts in the digital transformation of healthcare. These included the joint release with CAIR of a laryngoscope diagnostic model and the clinical retrospective validation of the “EchoCare” ultrasound model in the hospital’s obstetrics and gynaecology department. Prof Han emphasised that artificial intelligence has become a crucial driving force for the future of healthcare, stating that by deepening its application in clinical settings, it can significantly enhance both medical service efficiency and patient experience.

Prof Tat-Ming Danny CHAN, Clinical Associate Professor (Honorary) & Head of Division of Neurosurgery at the Department of Surgery, CUHK, delivered a keynote titled “The Global Clinical Challenges: Feeding, Bleeding and Washing”. He presented detailed clinical case studies and global data to explore three major global challenges in healthcare: accurate placement of nasogastric tubes, precise assessment of intraoperative blood loss, and standardising surgical cleaning processes. Prof Chan highlighted that AI technology is key to overcoming these clinical issues and called for closer collaboration between AI and medical teams, aiming to drive continuous improvements in global healthcare safety.

Prof Chwee Ming LIM, Head and Senior Consultant of Department of Otolaryngology-Head and Neck Surgery, Director of Department of Clinical Translational Research, Singapore General Hospital, Associate Professor, Duke NUS Medical School, delivered a compelling keynote on “Al Applications for Head and Neck Cancer”. He shared his latest breakthroughs in early cancer screening, imaging analysis, and surgical assistance, offering clinical insights into how these technologies are transforming patient care. Prof Lim highlighted that successful clinical translation relies on interdisciplinary collaboration, especially at the crossroads of medicine, engineering, and information science. Only by combining expertise across these fields can we expedite the transition of innovative technologies from the lab into real-world clinical applications, scaling them to improve patient outcomes on a global scale.

Prof Yongping ZHENG, Henry G. Leong Chair Professor of Biomedical Engineering, Director of Research Institute for Smart Ageing at PolyU, delivered an insightful talk on “AI for Enhancing Neuromuscular Ultrasound Imaging”. He presented his team’s latest breakthroughs, including the “sonomyography” (SMG) and other innovative technologies, showcasing the vast potential of combining AI with ultrasound for neuromuscular imaging, dynamic monitoring, and personalised healthcare. Prof Zheng emphasised that in the future, AI will become as fundamental and ubiquitous as electricity and the internet, and researchers should focus on specific problems, harnessing AI to create truly transformative solutions that can revolutionise medical practice.

Following this, a distinguished panel of experts shared their latest research and practical experiences. Prof Chee-Kong CHUI, Tenured Associate Professor at the Department of Mechanical Engineering, National University of Singapore, Dr Calvin MAK, Chairman of Innovation Committee and Smart Hospital Management Committee, Kowloon Central Cluster, Deputy Chief and Consultant Neurosurgeon, Queen Elizabeth Hospital, Prof Xinwu CUI, Director of Ultrasound Imaging Department, Chief Physician and Professor, Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Prof Ziyi CHEN, Deputy Director of Department of Neurology, Chief Physician and Professor, First Affiliated Hospital of Sun Yat-sen University, Prof Lei DU, Chief Physician and Professor at the Department of Anaesthesia, West China Hospital, Sichuan University, and Prof Kun QIAN, Co-founder and Chief Medical Officer of SenseCare, also shared their expertise. Their presentations offered a wealth of innovative ideas and solutions from multiple disciplines and sectors, broadening the horizons for interdisciplinary collaboration and industrial integration. These insights will undoubtedly shape the future direction of the healthcare industry, fostering collaboration between academia, medicine, and technology.

Additionally, the Symposium featured a series of engaging activities at the Hong Kong Science Park, including the CAIR Exhibition Hall tour, a sub-forum on the integration of medicine and engineering, and discussions on the global expansion of enterprises. These events were diverse and dynamic, not only highlighting cutting-edge technologies but also offering participants an excellent opportunity to explore pathways for industrialisation and exchange international insights.

During the CAIR Exhibition Hall tour, attendees had the opportunity to explore a range of groundbreaking technologies. These included the next-generation medical AI large model CARES 3.0, the EndoVision·Pulmonary from the First Affiliated Hospital, Sun Yat-sen University, the EndoVision·otolaryngology from Qilu Hospital in Shandong, the EchoCare Ultrasound Model, AI-enhanced augmented reality digital humans, embodied intelligent ultrasound robots, intraoperative low-field MRI imaging systems, real-time medical physical simulation platform–PRIME, operating room spatial understanding systems, and flexible robotic systems for minimally invasive brain surgery. Guests engaged in in-depth discussions with the developers regarding the performance, clinical applications, and market potential of these technologies. These conversations provided valuable insights and recommendations for advancing the translation of these innovations into practical, industry-ready solutions.

During the session on the integration of medicine and engineering, Mr Jiayin LIU, Director of Innovation and Industry Transformation at CAIR, provided a compelling overview of the Centre’s research capabilities, technological achievements, international resources, and versatile collaboration models. Dr Dong YI, Associate Researcher at CAIR, presented the latest advancements and applications of the medical multimodal AI model CARES 3.0, demonstrating its transformative potential in healthcare. Dr Yuan GAO, Senior Engineer at CAIR, delivered an in-depth presentation on the world’s first real-time medical multiphysics simulation system, highlighting its groundbreaking impact on medical technology. Through live demonstrations and engaging discussions, the session effectively brought CAIR closer to medical experts and industry leaders, strengthening partnerships and laying a robust foundation for future cross-disciplinary collaborations and innovative developments in the field.

The forum on “Global Expansion of Enterprises” was co-hosted by CAIR and the Hong Kong Science and Technology Parks Corporation, as part of the CREATE Symposium. The session featured a distinguished panel of experts, including Ms Yaping LEI, Chief Manager of Life and Health Sciences at Invest Hong Kong, Mr Zhong LI, Head of Medical Quality and Regulatory Affairs at Miconvey, Mr Dajiang LI, General Manager of Suzhou MicroPort NaviBot International LLC, Dr Huimei FENG, Founder and Clinical Evaluation Expert of Clindata, Mr Jiajin ZHANG, Business Development Senior Manager at Hong Kong Science and Technology Parks Corporation, Mr Weiquan GUAN, Director of Audit and Assurance at Deloitte China, and Mr Shoukang HUANG, Partner and Tax and Business Advisory at Deloitte China. The experts shared valuable insights on critical issues such as strategic planning, legal frameworks, market analysis, practical experience, the innovation ecosystem, taxation, and listing in Hong Kong. They also showcased successful industry case studies and practical experiences. During the subsequent roundtable discussion, Mr Weimin HONG, Founding Partner of Zebras Innovation Acceleration Platform, Mr Hualiang NI, Founder and CEO of OYMotion, Mr Weiquan GUAN, Mr Jiajin ZHANG, Mr Zhong LI, Dr Jiayin LIU, and other distinguished guests provided actionable advice and strategies for global market expansion. Their discussions instilled greater confidence in participants regarding future strategic decisions and global market positioning.

The symposium concluded successfully amidst vibrant and fruitful exchanges. Over the course of two days, the event successfully established a high-level dialogue platform that fostered cross-disciplinary integration and global connectivity, significantly enhancing collaboration between academia, industry, and research sectors. The distinguished academic presentations and in-depth analyses of cutting-edge industry trends not only provided participants with valuable strategic insights but also injected fresh momentum into the innovation and transformation of global medical technology. Moreover, the symposium further solidified and elevated Hong Kong’s position as a world-class hub for medical technology.

Looking ahead, CAIR will continue to partner with stakeholders from all sectors, driving forward global cooperation and collaborative innovation. Through the deep integration of cutting-edge technologies like embodied intelligence with medical practice, CAIR aims to generate more groundbreaking, original solutions, contributing intelligence and strength towards improving human health and elevating global healthcare services.

• Ample global spare capacity lowers risk of goods price inflation beyond tariffs as manufacturers trim inventories and purchasing
• North American manufacturers report steepest drop in material purchases since May, signaling weaker production ahead
• Chinese factories pull back buying, increasing spare capacity across Asia’s suppliers
• Europe’s manufacturing sector recovery continues to make slow progress

CLARK, N.J., Nov. 12, 2025 /PRNewswire/ — Manufacturers in North America reduced their purchases of raw materials and intermediate goods in October, according to the GEP Global Supply Chain Volatility Index, which based on a monthly survey of 27,000 businesses worldwide. The fall in input demand—a key early indicator of factory output—was the steepest since May and suggests that production in the region is set to cool in the coming months.

Interpreting the data: Index > 0, supply chain capacity is being stretched. The further above 0, the more stretched supply chains are. Index < 0, supply chain capacity is being underutilized. The further below 0, the more underutilized supply chains are.

The Volatility Index, which tracks demand conditions, shortages, transportation costs, inventories, and backlogs, registered –0.33 in October, indicating that global supply chain capacity remains underused. Manufacturers across major economies continued to keep inventories lean and curb new purchases of inputs.

In North America, the slowdown followed several months of tariff-driven stockpiling earlier in the year. Firms reported both lower material purchasing and a reduction in deliberate inventory building, taking pressure off supply chains which are now running well below full capacity.

Asia’s momentum also faded. A pullback in factory buying across China offset continued strength in India, leading to a broader softening across the region.

In Europe, manufacturers showed only a marginal increase in activity. Capacity at suppliers remains underutilized, and firms in Germany, France, Italy, and the U.K. continued to restrict raw material purchasing, underscoring a sluggish industrial recovery.

“North America is seeing the clearest sign yet of a manufacturing pullback,” said Michael DuVall, Vice President, Consulting, GEP. “Manufacturers are buying less and working down inventories, which points to weaker production through the winter. With space capacity across global supply we do not anticipate any price pressure, beyond tariffs, on buyers.”

OCTOBER 2025 REGIONAL KEY FINDINGS

• ASIA: Index dropped to -0.30, from -0.06, indicating greater spare capacity across supply chains into and across Asia. This was mostly driven by a slowdown in Chinese manufacturers’ purchasing.
• NORTH AMERICA: Index fell to its lowest level since March (-0.45 in October, vs. -0.25 previously), signaling capacity at the region’s suppliers went underutilized to the greatest extent since prior to April’s sweeping tariff announcements.
• EUROPE: Index rises to three-month high of -0.25, from -0.53, indicating unused manufacturing capacity as the region’s recovery from its protracted industrial downturn remains sluggish.
• U.K.: Sharp drop in index to -0.80, from -0.57, highlighting sharp reduction in activity at the U.K.’s suppliers.

OCTOBER 2025 KEY FINDINGS

• DEMAND: September’s boost in factory purchasing – the strongest since June 2022 – was reversed in October as manufacturers in key economies such as China and the U.S. reported slowdowns in procurement. Factories’ orders of commodities, components and intermediate goods remain subdued, indicating a soft near-term outlook for producers.
• INVENTORIES: Reports from global procurement managers of an increase in stockpiling due to price or supply fears remain historically low, indicating limited concern about purchasing price inflation or shortages. The data continue to demonstrate a preference among manufacturers for lean warehouses.
• MATERIAL SHORTAGES: The global item shortages tracker remains well below its long-term trend level, signaling healthy supply levels for the world’s manufacturers. Factories will have little, if any, challenges in sourcing vendors for commodities, components and other intermediate products.
• LABOR SHORTAGES: There was a modest rise in labor-related capacity constraints during October, with reports of backlogs rising due to inadequate staff supply ticking up to a four-month high. Nevertheless, the labor shortages tracker was only marginally above its long-term trend.
• TRANSPORTATION: Global transportation costs ticked down slightly in October to just below historically average levels.

For more information, visit www.gep.com/volatility.

Note: Full historical data dating back to January 2005 is available for subscription. Please contact economics@spglobal.com.

The next release of the GEP Global Supply Chain Volatility Index will be 8 a.m. ET, Dec. 10, 2025.

About the GEP Global Supply Chain Volatility Index

The GEP Global Supply Chain Volatility Index is produced by S&P Global and GEP. It is derived from S&P Global’s PMI® surveys, sent to companies in over 40 countries, totaling around 27,000 companies. The headline figure is a weighted sum of six sub-indices derived from PMI data, PMI Comments Trackers and PMI Commodity Price & Supply Indicators compiled by S&P Global.

• A value above 0 indicates that supply chain capacity is being stretched and supply chain volatility is increasing. The further above 0, the greater the extent to which capacity is being stretched.
• A value below 0 indicates that supply chain capacity is being underutilized, reducing supply chain volatility. The further below 0, the greater the extent to which capacity is being underutilized.

A Supply Chain Volatility Index is also published at a regional level for Europe, Asia, North America and the U.K. For more information about the methodology, click here.

About GEP

GEP® delivers AI-powered procurement and supply chain solutions that help global enterprises become more agile and resilient, operate more efficiently and effectively, gain competitive advantage, boost profitability and increase shareholder value. Fresh thinking, innovative products, unrivaled domain expertise, smart, passionate people — this is how GEP SOFTWARE™, GEP STRATEGY™ and GEP MANAGED SERVICES™ together deliver procurement and supply chain solutions of unprecedented scale, power and effectiveness. Our customers are the world’s best companies, including more than 1,000 Fortune 500 and Global 2000 industry leaders who rely on GEP to meet ambitious strategic, financial and operational goals. A leader in multiple Gartner Magic Quadrants, GEP’s cloud-native software and digital business platforms consistently win awards and recognition from industry analysts, research firms and media outlets, including Gartner, Forrester, IDC, ISG, and Spend Matters. GEP is also regularly ranked a top procurement and supply chain consulting and strategy firm, and a leading managed services provider by ALM, Everest Group, NelsonHall, IDC, ISG and HFS, among others. Headquartered in Clark, New Jersey, GEP has offices and operations centers across Europe, Asia, Africa and the Americas. To learn more, visit www.gep.com.

About S&P Global

S&P Global (NYSE: SPGI) S&P Global provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through ESG and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world. We are widely sought after by many of the world’s leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world’s leading organizations plan for tomorrow, today.

Media Contacts
Derek Creevey
Director, Public Relations
GEP
Phone: +1 646-276-4579
Email: derek.creevey@gep.com

Joe Hayes
Principal Economist
S&P Global Market Intelligence
Phone: +44-1344-328-099
Email: joe.hayes@spglobal.com

Interpreting the data: Index > 0, supply chain capacity is being stretched. The further above 0, the more stretched supply chains are. Index < 0, supply chain capacity is being underutilized. The further below 0, the more underutilized supply chains are.

GEP Global Supply Chain Volatility Index

Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem

NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ — Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today announced a strategic partnership designed to accelerate the integration of artificial intelligence and real-time clinical insight into digital dentistry.

The partnership brings together Medit’s open, global digital platform and OraQ’s advanced AI technologies to create new pathways for innovation and connectivity across the dental industry. Together, the companies aim to enhance how data is captured, analyzed, and applied—empowering dental professionals with meaningful insights that elevate care, improve outcomes, and drive growth.

By aligning their respective strengths, Medit and OraQ are working to redefine the role of data in dentistry—from a static record to a dynamic foundation for clinical intelligence. This collaboration reflects a shared vision: that digital tools should not only simplify workflows but also enable smarter, more connected, and more predictive patient care.

“Medit is redefining what a scan can do, and together we’re turning every image into insight—so providers can plan the right care, at the right time, for the right reasons,” said Dr. Amreesh Khanna, chief executive officer and founder of OraQ. “This partnership brings meaning to dental data. By embedding OraQ’s real-time risk intelligence directly into Medit’s workflow, we help every dentist see what matters most for their patient—clearly and confidently.”

“At Medit, we believe scanning should go beyond capturing data—it should create understanding. By integrating OraQ’s intelligence into our platform, we are empowering clinicians with instant insight that elevates care and connects dentistry to a broader picture of health,” said Han Ryu, chief executive officer at Medit. “Partnering with OraQ allows Medit users to see risk, opportunity, and patient health in real time, right at the chair. This is a breakthrough that makes scanning every patient, every visit, both clinically valuable and economically smart.”

The companies are working on a joint initiative that will leverage AI, real-time 3D scan analysis, and digital workflow innovation to expand the role of clinical intelligence in dentistry. The partnership is expected to accelerate the adoption of AI-driven care models and strengthen the bridge between dental and overall health.

About Medit

Medit is a global provider of 3D intraoral scanners and digital dentistry solutions based on proprietary technology. The company supports collaborative workflows between dental clinics and labs through innovative hardware and software solutions. Headquartered in Seoul, South Korea, since 2000, Medit has a strong global presence through its offices in the Americas and Europe and a distributor network spanning over one hundred countries.

About OraQ

OraQ is transforming dentistry by unifying dental and key medical data into one AI-powered clinical intelligence platform. Its mission is simple: make every dental visit a step toward better health. By integrating fragmented data systems into a unified intelligence layer, OraQ delivers clear, actionable risk insights and treatment recommendations that providers and patients understand — helping standardize care, improve outcomes, and unlock new revenue potential. Recognized as Best in Class in the Dental/Oral Health category at the 2025 Digital Health Awards, OraQ partners with leading universities and global technology providers—including Medit—to embed its AI into everyday diagnostic workflows, accelerating adoption and making precision dentistry accessible worldwide.

Media Contacts:
Tiffany Yang
Sr. Marketing Manager, Medit
tiffany.yang@medit.com 

William Johnson
Senior Advisor, Nevvco Strategies
william@nevvcostrategies.com 

LOS ANGELES, Nov. 12, 2025 /PRNewswire/ — Govee, a global leader in smart lighting innovation, is working with Disney for the first time to illuminate homes with an electrifying collaboration ahead of Walt Disney Animation Studios’ highly anticipated Zootopia 2, hitting theaters November 26. This magical collaboration goes beyond simply lighting, transforming outdoor spaces and inviting families and fans to immerse themselves in the film’s vibrant world alongside beloved characters, in their own homes.

“Lighting is an expression of joy,” said Eric Wu, CEO of Govee. “With our wide range of outdoor lights and DIY-friendly customization options, families can easily create an atmosphere that perfectly captures any mood or occasion. Our collaboration with Zootopia 2 is all about sparking imagination and fostering family connections, and making every moment at home feel a little bit more magical.”

Make Every Moment Wild With Govee Outdoor Lights

Just like the exciting world in Zootopia 2, Govee Outdoor Lights can turn ordinary nights into extraordinary memory making adventures.  Imagine backyard movie nights under a canopy of color, or festive family gatherings brought to life with dynamic lightscapes. Govee brings the big screen experience directly to your outdoor living space. And with the SceneStage feature in the Govee Home App, multiple lights work together seamlessly, creating vivid, dynamic displays that bring stories and celebrations to life. And with this collaboration fans can now celebrate their favourite Zootopia 2 characters with exclusive light scenes celebrating the film. Using  outdoor lighting solutions such as Govee Permanent Outdoor Lights Prism, Govee Curtain Lights Pro, Govee Christmas Sparkle String Lights, Govee Outdoor Garden Lights, and Govee Outdoor UpDown Wall Light, fans can easily access character-themed effects for Judy, Nick, Flash, and Gary De’Snake directly in the Govee Home App, or combine them to  a Zootopia 2 light show.

About Govee

Govee has been revolutionizing the smart living experience with innovative, ambient lighting solutions since 2017. From living spaces, gaming setups, and outdoor areas, Govee’s smart home tech is not just visually stunning, but also functional – transforming small everyday moments into more personalized and brighter engaging lighting experiences. Embracing the idea that users should “Life is Colorful” and push the boundaries of what lighting can do by blending design, and utility. To learn more about Govee, please visit govee.com.

About Walt Disney Animation Studios‘ Zootopia 2

In “Zootopia 2,” rookie cops Judy Hopps (voiced by Ginnifer Goodwin) and Nick Wilde (voiced by Jason Bateman) find themselves on the twisting trail of a great mystery when Gary De’Snake (voice of Academy Award® winner Ke Huy Quan) arrives in Zootopia and turns the animal metropolis upside down. To crack the case, Judy and Nick must go undercover to unexpected new parts of town, where their growing partnership is tested like never before. The Oscar®-winning team of Jared Bush and Byron Howard (directors) and Yvett Merino (producer) are the principal filmmakers.